Article
Onset of visual symptoms was gradual in 20-year-old woman: What is your diagnosis? Download the exam (PDF) and return it by August 15, 2004 to earn CME credit.
Outlook Therapeutics completes analysis of 12-week safety and efficacy results of NORSE EIGHT
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
How food choices may affect non-refractive visual impairment
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
RhyGaze secures Series A financing of $86 million to further novel gene therapy
Ashvattha Therapeutics secures $50M in financing to advance clinical trials